Wong, Kenneth C. W.
Hui, Edwin P.
Lo, Kwok-Wai http://orcid.org/0000-0002-3488-6124
Lam, Wai Kei Jacky http://orcid.org/0000-0001-8922-5609
Johnson, David
Li, Lili
Tao, Qian http://orcid.org/0000-0001-5383-4808
Chan, Kwan Chee Allen
To, Ka-Fai
King, Ann D.
Ma, Brigette B. Y. http://orcid.org/0000-0003-4802-1102
Chan, Anthony T. C. http://orcid.org/0000-0002-6912-8091
Article History
Accepted: 18 May 2021
First Online: 30 June 2021
Competing interests
: E.P.H. has received speaker’s honoraria from Merck Serono and Merck Sharpe and Dohme (MSD), and is a consultant and advisory board member for MSD. W.K.J.L. holds equity in Grail, and holds patents and patent applications related to molecular diagnostics. K.C.A.C. holds equity in Dra Company Limited (DRA), Grail and Take2, is a consultant to Grail, a director of DRA and Take2, holds patents and patent applications related to molecular diagnostics, and receives royalties from DRA, Grail, Illumina, Take2 and Xcelom. B.B.Y.M. is an advisory board member and receives speaker’s honoraria from Bristol Myers Squibb, Merck Serono, MSD and Novartis, and is a consultant for Y-Biologics. A.T.C.C. receives research funding from Merck Serono, MSD and Pfizer, and is an advisory board member for MSD and Tessa Therapeutics. All other authors declare no competing interests.